Voriconazole
Edina Avdic, Pharm.D.
Pediatric Dosing Author: Bethany Sharpless Chalk, Pharm.D., BCPPS
Voriconazole is a topic covered in the
Johns Hopkins ABX Guide.
To view the entire topic, please log in or purchase a subscription.
Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

-- The first section of this topic is shown below --
INDICATIONS
- Voriconazole is FDA approved for the following indications in adults and pediatrics ≥ 2 years of age:
- Prophylaxis of invasive aspergillosis and disseminated candidiasis in severely immunocompromised hosts
- Based on in-vitro data and limited clinical experience, voriconazole may be effective for infections due to certain dematiaceous fungi (C. immitis)
-- To view the remaining sections of this topic, please log in or purchase a subscription --
INDICATIONS
- Voriconazole is FDA approved for the following indications in adults and pediatrics ≥ 2 years of age:
- Prophylaxis of invasive aspergillosis and disseminated candidiasis in severely immunocompromised hosts
- Based on in-vitro data and limited clinical experience, voriconazole may be effective for infections due to certain dematiaceous fungi (C. immitis)
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2022 Unbound Medicine, Inc. All rights reserved